ArticleJournal of Cancer2025

Efficacy and Safety of Immune Checkpoint Inhibitor Rechallenge in the Treatment of Esophageal Squamous Cell Cancer.

Xiaojing Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.